Qual é o preço para Quest PharmaTech Inc. (QPTFF)

O preço para Quest PharmaTech Inc. (QPTFF) é $0.02

Qual é a capitalização de mercado para Quest PharmaTech Inc. (QPTFF)

A capitalização de mercado para Quest PharmaTech Inc. (QPTFF) é $3.38M

Quest PharmaTech Inc. (QPTFF) Índice P/V

Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm, specializes in creating antibody-driven immunotherapeutic remedies primarily for various cancers. A cornerstone of its product pipeline is Mab AR 9.6, an advanced therapeutic candidate specifically designed to target truncated O-glycans on MUC16 for precise cancer treatment applications. The company's offerings further encompass Oregovomab, an anti-CA-125 antibody that has successfully completed Phase II clinical trials for the management of ovarian cancer. Beyond these specific agents, Quest PharmaTech is actively involved in the development, manufacturing, and commercialization of new immunotherapy products aimed at combating pancreatic cancer. The organization also diversifies its portfolio by utilizing proprietary transdermal delivery technologies to formulate products for dermatological conditions and wound healing. Additionally, it develops specialized skin-penetrating active molecules for use in both cosmetic and pharmaceutical goods. Rounding out its innovative efforts, Quest PharmaTech designs intricate combinatorial immunotherapies for cancer, employing monoclonal antibodies belonging to both immunoglobulin G and E classes.

Ano	Rácio P/S	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Rácio P/S

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Rácio P/S	Diferença do rácio P/S	País
Vertex Pharmaceuticals Incorporated VRTX.US	10.17	-	US
Argenx SE ARGX.US	10.13	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	4.74	-	BE

Empresa

Rácio P/S

Diferença do rácio P/S

País